<i>In silico</i> design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populationsYi Yang, Yusen Zhou, Xia Jin et al.|Human Vaccines & Immunotherapeutics|2015Cited by 156
A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length proteinJingjing Guo, Yusen Zhou, Yi Yang et al.|Vaccine|2015Cited by 12
A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infectionYi Yang, Yusen Zhou, Qing Zhu et al.|Human Vaccines & Immunotherapeutics|2017Cited by 6
TFPR1 acts as an immune regulator and an efficient adjuvant for proteins and peptides by activating immune cells, primarily through TLR2Weilai Sun, Zhihua Kou, Qiao Li et al.|Vaccine|2019Cited by 5